Skip to content

Effects of preoperative amino acid infusion on the duration of Rocuronium during laparotomy (non-randomized comparative study)

Effects of preoperative amino acid infusion on the duration of Rocuronium during laparotomy (non-randomized comparative study) - Effects of amino acid infusion on the duration of Rocuronium

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034556
Enrollment
40
Registered
2018-10-18
Start date
2018-10-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparotomy

Interventions

amino acid infusion group placebo (saline) control

Sponsors

Division of Clinical Research National Health Organization Mito Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients scheduled laparotomy(malignant & non-malignant diseases)

Exclusion criteria

Exclusion criteria: patients taking drugs which affect the duration of Rocuronium

Design outcomes

Primary

MeasureTime frame
duration of Rocuronium

Countries

Japan

Contacts

Public ContactKazuhiro Watanabe

National Health Organization Mito Medical Center Department of Anesthesiology

atenza.kazuhirowatanabe@gmail.com029-240-7711

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026